From January23-25, 2019, the sales and technical team of Standard Pharma came to theShanghai office of Gattefosse for a three-day year-end summary and technicalexchange and training activity.
The meetingstarted from Ms. Eileen Liu’s summary of 2018 and outlook of 2019. In 2019, Gattefossewill apply for the CDMF of 6-7 products of Gattefosse in a planned way,adhering to the purpose of serving customers wholeheartedly.
Mr. Ivan Guan,general manager of Standard Pharma, and regional sales leaders summarized and prospected the situation of Standard Pharma. Mr. Simon Zi, the business manager of Gattefosse, analyzed and summarized the market situation, the technical manager brought us the research results of Gattefosse laboratory, the regional market development manager Mr. Jocab Yu pointed out the opportunity direction of Gattefosse product.
At the meeting, technical manager Carol Wang explained in detail the suppository-related work done by Gattefosse laboratory in 2018 with the case study of nitroimidazoles. The meeting confirmed that Gattefosse laboratory will increase support for the quality consistency reevaluation of suppositories in 2019. The laboratory has rich experience in testing the dissolution and softening time of suppositories, and plans to fully communicate with the pharmacopoeia committee and actively cooperate to fill the gap in this field in China.
During the meeting and training, not only showed the comparative experiment of thermal stability and softening time of suppositories and the preparation and dilution resistance observation experiment of veterinary self-emulsifying preparation,but also let the team of Standard Pharma experience the preparation process of blank cream, blank gel and diclofenacate sodium foam.
During the three-day training and communication, Standard Pharma sales and technical team had a deeper understanding of Gattefosse products, which laid a solid foundation for the market promotion in 2019 and the efficient and professional provision of quality services for customers.
Gattefosse hasproducts in the fields of medicine and personal care. Relying on the backgroundof the cosmetics department, Gattefosse pharmaceutical products have a hugeadvantage in external use of auxiliary materials. As soon as the draft forexternal use of preparations was released on July 24, 2018, Gattefosse took anactive part in the related work. The professional laboratory equipment of Gattefosselaboratory also provides support for customers for free, and a number ofcustomers have successively carried out experiments related to the developmentand evaluation of external products in Gattefosse laboratory.
We are lookingforward to more communication with you!
